title: The economic impact of addressing the organ shortage with clinically high-risk allografts.
abstract: Expanding gaps between the number of patients awaiting transplantation and the number who receive organs in the United States has been associated with heightened disease severity among transplant candidates and more common use of organs from non-standard donors. We summarize data on the economic consequences of liver and renal allograft quality in contemporary practice. Policy makers and providers must work together to ensure that financial disincentives do not lead to wastage of lifesaving organs.
authors: Department of Internal Medicine, Saint Louis University Center for Outcomes Research, USA. lentinek@slu.edu
authors: Krista L
authors: KL
authors: Lentine
authors: Mark A
authors: MA
authors: Schnitzler
mesh_terms: D017281:Cost of Illness; D006801:Humans; D016030:Kidney Transplantation / Q000191:economics* / Q000592:standards / Q000706:statistics & numerical data; D016031:Liver Transplantation / Q000191:economics* / Q000592:standards / Q000706:statistics & numerical data; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution*; D009927:Tissue and Organ Procurement / Q000191:economics* / Q000592:standards; D014184:Transplantation, Homologous / Q000191:economics / Q000592:standards; D014481:United States; D014850:Waiting Lists